Skip to main content
Skip to content
Case File
efta-01522063DOJ Data Set 10Other

EFTA01522063

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01522063
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL- OAP FDC ACCT. For the Period 8/1/11 to 8/31/11 Equity Summary Asset Categories Beginning Ending Change Gwent Market Value Market Value In Value Allocation US Large Cap Equity 0.00 150,689.08 150,689.08 98% Market Value/Cost Current Period Value Market Value 150,689.06 Tax Cost 147,157.52 Unrealized Gain/Loss 3,531.56 Estimated Annual Income 5219.44 Accrued Dividends 594.23 Yield 3.46% Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 52.51 148.000 7,771.48 7,308.74 462.74 284.16 3.66% 00282410-0 ABT AIR PRODUCTS & CHEMICALS INC 81.87 86.000 7,040.82 7,148.42 (107.60) 199.52 2.83% 009158-10-6 APD AUTOMATIC DATA PROCESSING INC 50.03 150.000 7,504.50 7,264.05 240.45 216.00 2.88% 053015-10-3 ADP J.P, Morgan Page 4 of 14 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049537 SDNY_GM_00318735 EFTA01522063

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.